Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC

ABSTRACT: Interventions: Total:FOLFIRI based chemotherapy Primary outcome(s): Toxicity related TTF;Incidence of side effects (Grade3 to 4);ORR Study Design: Cohort study

DISEASE(S): Colorectal Cancer

PROVIDER: 2671500 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR